- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
Hugel
Market Cap: ₩2.5t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩233,500.00
7D
-2.5%
1Y
-34.2%
Dong-A Socio Holdings
Market Cap: ₩538.3b
Engages in the pharmaceutical business in South Korea.
A000640
₩81,800.00
7D
-2.7%
1Y
-29.8%
Dong-A ST
Market Cap: ₩334.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩35,850.00
7D
1.6%
1Y
-22.6%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩119,200.00
7D
-11.6%
1Y
-27.5%
PharmaResearch
Market Cap: ₩3.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩327,500.00
7D
0.2%
1Y
-42.9%
Hanmi Pharm
Market Cap: ₩4.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩388,500.00
7D
-5.0%
1Y
36.8%
Medy-Tox
Market Cap: ₩456.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩72,400.00
7D
-0.8%
1Y
-55.4%
SK Biopharmaceuticals
Market Cap: ₩5.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩78,400.00
7D
-4.5%
1Y
-19.6%
ST PharmLtd
Market Cap: ₩2.7t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩123,000.00
7D
2.3%
1Y
39.9%